Cargando…
Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer
BACKGROUND: Triple negative breast cancer (TNBC) has the poorest prognosis of all breast cancer subtypes and is one of the most fatal diseases for women. Combining cytotoxic chemotherapy with immunotherapy has shown great promise for TNBC treatment. However, chemotherapy often leads to the developme...
Autores principales: | Yuan, Shen-Jun, Xu, Yong-Hong, Wang, Chao, An, Hui-Chao, Xu, Hua-Zhen, Li, Ke, Komatsu, Naoki, Zhao, Li, Chen, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798483/ https://www.ncbi.nlm.nih.gov/pubmed/31623629 http://dx.doi.org/10.1186/s12951-019-0541-8 |
Ejemplares similares
-
Polyglycerol-functionalized nanodiamond as a platform for gene delivery: Derivatization, characterization, and hybridization with DNA
por: Zhao, Li, et al.
Publicado: (2014) -
Synergy of nanodiamond–doxorubicin conjugates and PD-L1 blockade effectively turns tumor-associated macrophages against tumor cells
por: Xu, Hua-Zhen, et al.
Publicado: (2021) -
Nanodiamond-DGEA peptide conjugates for enhanced delivery of doxorubicin to prostate cancer
por: Salaam, Amanee D, et al.
Publicado: (2014) -
Stability of DMPC Liposomes Externally Conjugated with Branched Polyglycerol
por: Beketov, Alexander A., et al.
Publicado: (2022) -
Epirubicin-Adsorbed Nanodiamonds Kill Chemoresistant Hepatic Cancer Stem Cells
por: Wang, Xin, et al.
Publicado: (2014)